Fentanyl Concerns Resurface as Trump's Tariff Threats Loom Over China

During President-elect Donald J. Trump’s initial term, discussions between China and the United States to tackle the opioid crisis, particularly fentanyl trafficking, saw a temporary collaboration. However, rising trade tensions soon derailed these efforts. Trump's renewed focus on imposing tariffs as a means to curb the flow of fentanyl from China raises significant concerns among experts.Fentanyl, a synthetic opioid responsible for a staggering number of deaths in the United States, is primarily manufactured using precursor chemicals sourced from China. While recent efforts by Chinese officials to increase oversight by adding more chemicals to their controlled list indicate some willingness to collaborate post-Biden-Xi discussions, skepticism prevails over the effectiveness and durability of such cooperation.Critics argue that the proposed tariffs could backfire, potentially ending the collaborative efforts that have made rare progress amidst strained U.S.-China relations. Vanda Felbab-Brown, a senior fellow specializing in global drug policy at the Brookings Institution, warns that leaping to impose tariffs will not diminish the fentanyl supply and could actually reverse the counternarcotics cooperation that had just begun to flourish after two years of stagnation.Despite some positive movements, those familiar with the situation emphasize that tighter controls on precursor chemicals alone won't suffice. Chinese manufacturers can adapt swiftly by introducing new unchecked substances, making intensified cooperation between U.S. and Chinese law enforcement essential. Strengthening frameworks for anti-money laundering could also play a critical role in disrupting the financial channels that support fentanyl trafficking.In a complex landscape where geopolitical challenges are intertwined with public health crises, the stakes remain high as both nations navigate this precarious balance.